Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Mar 06, 2007 1:12pm
225 Views
Post# 12364742

RE: Barcodewhiz

RE: Barcodewhiz I feel great about recent developments, but just havent posted much. I am a little weary of all the new clones, and also the constant negativity. The Catalyst situation is unfolding almost exactly as I had hoped. The next step is some kind of joint deal with Catalyst and Prometic... it will be interesting to see whether Melnyk is involved. At this point, with the prospect of being dealt out completely and losing his up front money, I assume he is at the bargaining table to come away with something. I expect to see some kind of comprehensive JV deal announced within the next month or two, and I expect it to be another very positive catalyst for the stock. I also expect some meaningful developments on the PRDT / Macopharma filter front. I know Pierre has spent quite a bit of time over there recently, wouldnt surprise me at all if we finally get some progress or the long awaited lead orders from one of the blood agencies. Havent heard anything on 1402, but hope things are progressing. I think the stock is hanging in primarilly because of the prospect of the Catalyst and PRDT situations developing in short order.
Bullboard Posts